IL70198A - 6,7-dihydro-5,8-dimethyl-9-fluoro-1-oxo-1h,5h-benzo(ij)quinolizine-2-carboxylic acid and derivatives thereof,their preparation and pharmaceutical compositions containing them - Google Patents
6,7-dihydro-5,8-dimethyl-9-fluoro-1-oxo-1h,5h-benzo(ij)quinolizine-2-carboxylic acid and derivatives thereof,their preparation and pharmaceutical compositions containing themInfo
- Publication number
- IL70198A IL70198A IL70198A IL7019883A IL70198A IL 70198 A IL70198 A IL 70198A IL 70198 A IL70198 A IL 70198A IL 7019883 A IL7019883 A IL 7019883A IL 70198 A IL70198 A IL 70198A
- Authority
- IL
- Israel
- Prior art keywords
- quinolizine
- benzo
- dihydro
- oxo
- fluoro
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- DXKRGNXUIRKXNR-UHFFFAOYSA-N ibafloxacin Chemical compound C1CC(C)N2C=C(C(O)=O)C(=O)C3=C2C1=C(C)C(F)=C3 DXKRGNXUIRKXNR-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 4
- 239000002253 acid Substances 0.000 abstract 2
- -1 alkylaminoalkyl ester salts Chemical class 0.000 abstract 2
- 150000001263 acyl chlorides Chemical class 0.000 abstract 1
- 239000004599 antimicrobial Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
- C07D455/03—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
- C07D455/04—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Quinoline Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/441,245 US4472405A (en) | 1982-11-12 | 1982-11-12 | Antimicrobial 6,7-dihydro-5,8-dimethyl-9 fluoro-1-oxo-1H, 5H-benzo (ij) quinolizine-2-carboxylic acid and derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL70198A0 IL70198A0 (en) | 1984-02-29 |
| IL70198A true IL70198A (en) | 1988-11-15 |
Family
ID=23752110
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL70198A IL70198A (en) | 1982-11-12 | 1983-11-11 | 6,7-dihydro-5,8-dimethyl-9-fluoro-1-oxo-1h,5h-benzo(ij)quinolizine-2-carboxylic acid and derivatives thereof,their preparation and pharmaceutical compositions containing them |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US4472405A (cs) |
| EP (1) | EP0109284B1 (cs) |
| JP (1) | JPH0826017B2 (cs) |
| KR (1) | KR890000864B1 (cs) |
| AT (1) | ATE39926T1 (cs) |
| AU (1) | AU568319B2 (cs) |
| CA (2) | CA1254568A (cs) |
| CS (1) | CS390391A3 (cs) |
| DE (1) | DE3378912D1 (cs) |
| EG (1) | EG16492A (cs) |
| ES (1) | ES8504727A1 (cs) |
| FI (1) | FI73213C (cs) |
| GR (1) | GR79402B (cs) |
| IE (1) | IE56232B1 (cs) |
| IL (1) | IL70198A (cs) |
| IN (1) | IN161391B (cs) |
| MX (1) | MX7314E (cs) |
| NO (1) | NO160782C (cs) |
| NZ (1) | NZ206233A (cs) |
| OA (1) | OA07586A (cs) |
| PT (1) | PT77649B (cs) |
| ZA (1) | ZA838436B (cs) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3519926A1 (de) * | 1985-06-04 | 1986-12-04 | Bayer Ag | Indolinderivate, verfahren zu ihrer herstellung und diese indolinderivate enthaltende kosmetische lichtschutzmittel |
| CA1302413C (en) * | 1986-01-22 | 1992-06-02 | Bruce E. Williams | Process for 6,7-dihydro-5,8-dimethyl-9-fluoro-1-oxo- 1h,5h-benzo[ij]quinolizine-2-carboxylic acid |
| US4898945A (en) * | 1986-01-22 | 1990-02-06 | Minnesota Mining And Manufacturing Company | Process for 6,7-dihydro-5,8-dimethyl-9-fluoro-1-oxo-1H,5H-benzo[i,j]quinolizine-2-carboxylic acid |
| GB9827865D0 (en) * | 1998-12-18 | 1999-02-10 | Woodcock Fiona | Medicament |
| DE10312346A1 (de) * | 2003-03-20 | 2004-09-30 | Bayer Healthcare Ag | Kontrolliertes Freisetzungssystem |
| DE10351448A1 (de) | 2003-11-04 | 2005-06-09 | Bayer Healthcare Ag | Geschmackstoffhaltige Arzneimittelformulierungen mit verbesserten pharmazeutischen Eigenschaften |
| DE102005055385A1 (de) * | 2004-12-09 | 2006-06-14 | Bayer Healthcare Ag | Arzneimittel zur hygienischen Applikation im Ohr |
| DE102006010642A1 (de) * | 2006-03-08 | 2007-09-27 | Bayer Healthcare Aktiengesellschaft | Arzneimittelformulierungen, enthaltend Fluorchinolone |
| DE102006010643A1 (de) | 2006-03-08 | 2007-09-13 | Bayer Healthcare Aktiengesellschaft | Arzneimittel enthaltend Fluorchinolone |
| DE102007026550A1 (de) * | 2007-06-08 | 2008-12-11 | Bayer Healthcare Ag | Extrudate mit verbesserter Geschmacksmaskierung |
| DE102007055341A1 (de) | 2007-11-19 | 2009-05-20 | Bayer Animal Health Gmbh | Stabilisierung öliger Suspensionen enthaltend hydrophobe Kieselsäuren |
| AU2011315555B2 (en) | 2010-10-12 | 2016-03-10 | Elanco Animal Health Gmbh | Non-starch based soft chewables |
| US10543170B2 (en) | 2012-12-19 | 2020-01-28 | Bayer Animal Health Gmbh | Tablets with improved acceptance and good storage stability |
| MD4291C1 (ro) * | 2013-12-27 | 2015-02-28 | Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова | Preparat medicamentos pentru tratamentul otitelor |
| CN114727622A (zh) * | 2019-09-06 | 2022-07-08 | 礼蓝美国公司 | 适口颗粒状兽用药组合物 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE793524A (fr) * | 1971-12-30 | 1973-06-29 | Riker Laboratories Inc | Acides benzoquinolizine-carboxyliques et leurs derives |
| ZA728444B (en) * | 1971-12-30 | 1973-10-31 | Riker Laboratories Inc | Substituted benzo(ij)quinolizine-2-carboxylic acids and derivatives thereof |
| JPS5630964A (en) * | 1979-08-22 | 1981-03-28 | Kyorin Pharmaceut Co Ltd | Novel substituted quinolinecarboxylic acid and its preparation |
| JPS5655388A (en) | 1979-10-11 | 1981-05-15 | Otsuka Pharmaceut Co Ltd | Benzo ij quinolidine-2-carboxylic acid derivative, and its preparation |
| US4301289A (en) * | 1980-02-19 | 1981-11-17 | Minnesota Mining And Manufacturing Company | Process for 6,7-dihydro-9-fluoro-5-methyl-1-oxo-1H,5H-benzo(ij)quinolizine-2-carboxylic acid |
| JPS59155381A (ja) * | 1983-02-22 | 1984-09-04 | Kyorin Pharmaceut Co Ltd | ベンゾキノリジンカルボン酸誘導体及びその製造法 |
-
1982
- 1982-11-12 US US06/441,245 patent/US4472405A/en not_active Expired - Lifetime
-
1983
- 1983-10-27 CA CA000439826A patent/CA1254568A/en not_active Expired
- 1983-11-09 NO NO834093A patent/NO160782C/no unknown
- 1983-11-10 OA OA58156A patent/OA07586A/xx unknown
- 1983-11-10 ES ES527163A patent/ES8504727A1/es not_active Expired
- 1983-11-11 PT PT77649A patent/PT77649B/pt not_active IP Right Cessation
- 1983-11-11 ZA ZA838436A patent/ZA838436B/xx unknown
- 1983-11-11 NZ NZ206233A patent/NZ206233A/en unknown
- 1983-11-11 JP JP58212306A patent/JPH0826017B2/ja not_active Expired - Lifetime
- 1983-11-11 MX MX8310883U patent/MX7314E/es unknown
- 1983-11-11 AT AT83306908T patent/ATE39926T1/de not_active IP Right Cessation
- 1983-11-11 IN IN1382/CAL/83A patent/IN161391B/en unknown
- 1983-11-11 IL IL70198A patent/IL70198A/xx not_active IP Right Cessation
- 1983-11-11 EP EP83306908A patent/EP0109284B1/en not_active Expired
- 1983-11-11 DE DE8383306908T patent/DE3378912D1/de not_active Expired
- 1983-11-11 GR GR72947A patent/GR79402B/el unknown
- 1983-11-11 AU AU21181/83A patent/AU568319B2/en not_active Ceased
- 1983-11-11 FI FI834147A patent/FI73213C/fi not_active IP Right Cessation
- 1983-11-11 IE IE2639/83A patent/IE56232B1/en not_active IP Right Cessation
- 1983-11-12 EG EG70383A patent/EG16492A/xx active
- 1983-11-12 KR KR1019830005376A patent/KR890000864B1/ko not_active IP Right Cessation
-
1988
- 1988-08-05 CA CA000574069A patent/CA1280755C/en not_active Expired - Fee Related
-
1991
- 1991-12-19 CS CS913903A patent/CS390391A3/cs unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ATE39926T1 (de) | 1989-01-15 |
| EP0109284B1 (en) | 1989-01-11 |
| FI834147A (fi) | 1984-05-13 |
| IE56232B1 (en) | 1991-05-22 |
| IL70198A0 (en) | 1984-02-29 |
| KR840006659A (ko) | 1984-12-01 |
| JPH0826017B2 (ja) | 1996-03-13 |
| JPS59112969A (ja) | 1984-06-29 |
| US4472405A (en) | 1984-09-18 |
| PT77649B (en) | 1986-03-19 |
| CA1280755C (en) | 1991-02-26 |
| NO834093L (no) | 1984-05-14 |
| IN161391B (cs) | 1987-11-28 |
| EG16492A (en) | 1994-11-30 |
| FI73213B (fi) | 1987-05-29 |
| NO160782C (no) | 1989-05-31 |
| PT77649A (en) | 1983-12-01 |
| CS390391A3 (en) | 1992-09-16 |
| MX7314E (es) | 1988-05-11 |
| CA1254568A (en) | 1989-05-23 |
| FI73213C (fi) | 1987-09-10 |
| DE3378912D1 (de) | 1989-02-16 |
| ZA838436B (en) | 1985-06-26 |
| NZ206233A (en) | 1986-10-08 |
| IE832639L (en) | 1984-05-12 |
| FI834147A0 (fi) | 1983-11-11 |
| KR890000864B1 (ko) | 1989-04-11 |
| OA07586A (fr) | 1985-03-31 |
| EP0109284A1 (en) | 1984-05-23 |
| ES527163A0 (es) | 1985-05-01 |
| ES8504727A1 (es) | 1985-05-01 |
| AU2118183A (en) | 1984-05-17 |
| NO160782B (no) | 1989-02-20 |
| GR79402B (cs) | 1984-10-22 |
| AU568319B2 (en) | 1987-12-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL70198A (en) | 6,7-dihydro-5,8-dimethyl-9-fluoro-1-oxo-1h,5h-benzo(ij)quinolizine-2-carboxylic acid and derivatives thereof,their preparation and pharmaceutical compositions containing them | |
| PT80773A (en) | Process for the preparation of substituted benzoate ester prodrug derivatives of 3-hydroxymorfinans intermediates thereto and of pharmaceutical compositions containing the same | |
| HUT42447A (en) | Process for preparing novel benzol derivatives and pharmaceutical compositions comprising the same as active substance | |
| DK159778A (da) | Forbindelsesstik til flade traadkabler | |
| ES8702405A1 (es) | Procedimiento para la obtencion de acidos benzo(ij) quinolizina-2-carboxilicos y sus derivados | |
| JPS5726641A (en) | Use of substituted derivative of 4-phenyl-4-oxo-2-butenoic acid as drug | |
| JPS57108066A (en) | 4-substituted-2-oxoazetidine derivative and its preparation | |
| ES2001852A6 (es) | Procedimiento para preparar un derivado de acido quinolocarboxilico | |
| NZ193107A (en) | 1-hydroxy-2-piperazinylethyl derivatives of benzoic acid pharmaceutical compositions | |
| HUT42088A (en) | Process for preparing a benzothiazole-s-oxide derivative with antipsychotic activity and pharmaceutical compositions containing this compound as active ingredient | |
| JPS56121493A (en) | Preparation of micophenol acid derivative | |
| SE8301687L (sv) | 8-cyano-6,7-dihydro-5-metyl-1-oxo-1h-,5h-benso(ij)kinolizin-2-karboxylsyror och forfarande for framstellning derav | |
| PT72619B (en) | Novel quinoline derivatives pharmaceutical compositions con- taining such compounds and methods for the preparation of these compounds | |
| AU4478489A (en) | Intermediates for the preparation of penem derivatives | |
| GB2102812B (en) | Therapeutically active compounds from species of rubia synthetic derivatives thereof, methods for the production thereof and pharmaceutical compositions comprising the same | |
| JPS57203067A (en) | Novel quinolinecarboxylic acid derivatives, their preparations, and antibacterial agent comprising them as active ingredient | |
| IT8025781A0 (it) | Composizione farmaceutica per la somministrazione orale del metilestere dell'acido 13a-etil-2,3,5,6,12,13,13a,13b-ottaidro-12-idrossi1h-indolo-[3,2,1-de] pirido [3,2,1-ij] [1,5] naftiridina -12-carbossilico | |
| EP0203795A3 (en) | Benzo ûi,j¨ quinolizine-2-carboxylic acid derivatives, the salts and their hydrates, pharmaceutical compositions thereof, and process for preparing the same | |
| HUT50044A (en) | Process for producing pharmaceutical composition comprising megestrol acetate as active ingredient | |
| JPS57146775A (en) | 1,8-naphthyridine derivative and its salt | |
| DK550183A (da) | 6,7-dihydro-5,8-dimethyl-9-fluor-1-oxo-1h,5h-benzo/ij/-quinolizin-2-carboxylsyre, fremgangsmaade til fremstilling deraf og mellemprodukter til brug ved udoevelse af fremgangsmaaden | |
| JPS57183737A (en) | Use of phenylaliphatic carboxylic acid derivative as drug | |
| IE57163B1 (en) | Novel penem compounds,pharmaceutical compositions containing them,processes for their preparation | |
| HUT60736A (en) | Process for producing derivatives of 3-l-(5-thioxo-l-prolyl)-thiazolidine-4-carboxylic acid and pharmaceutical compositions comprising same as active ingredient | |
| AU529728B2 (en) | Esters of arylpropionic acid derivatives, their preparation and pharmaceutical compositions containing them |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| KB | Patent renewed | ||
| RH | Patent void | ||
| KB | Patent renewed | ||
| EXP | Patent expired |